Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 15, 2021
In situ spatial glycomic imaging of mouse and human Alzheimer's disease brainsTara R Hawkinson, Harrison A Clarke, Lyndsay E A Young, et al.
Academic Pathology|September 6, 2021
Pathology Residency Program Special Expertise Tracks Meet the Needs of an Evolving FieldLaura M Wake, Derek B Allison, Alisha D Ware, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signalingChaohao Li, Derek B Allison, Daheng He, et al.
Cell Reports|July 5, 2024
Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosisYanquan Zhang, Ka-Wing Fong, Fengyi Mao, et al.
Cancer Cytopathology|May 31, 2022
Multi-institutional validation of a modified scheme for subcategorizing salivary gland neoplasm of uncertain malignant potential (SUMP)Jen-Fan Hang, Jaslyn Jie Lin Lee, Min En Nga, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
PLK1-mediated phosphorylation of PHGDH reprograms serine metabolism in advanced prostate cancerXiongjian Rao, Derek B Allison, Robert M Flight, et al.
JCO Precision Oncology|September 14, 2022
Molecular Tumor Board-Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical TrialRachel W Miller, Megan L Hutchcraft, Heidi L Weiss, et al.
Plos Genetics|November 21, 2023
Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signalingChaohao Li, Derek B Allison, Daheng He, et al.
Cancer Research|August 11, 2022
Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint TherapyZhuangzhuang Zhang, Lijun Cheng, Jie Li, et al.
Cancers|May 13, 2023
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate CancerZin W Myint, William H St Clair, Stephen E Strup, et al.
Pageof 10